Could a simple 3D ultrasound replace a surgical scope for bleeding diagnosis?
NCT ID NCT07309692
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two methods for finding the cause of abnormal bleeding in women aged 40-55: a non-invasive 3D ultrasound and a more invasive hysteroscopy (a camera inserted into the uterus). Researchers will check how accurate the 3D ultrasound is compared to hysteroscopy. The goal is to see if the simpler ultrasound can reliably diagnose the problem, potentially avoiding the need for a surgical procedure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, 3D ultrasound could become a reliable, less invasive first step for diagnosing perimenopausal bleeding, reducing the need for hysteroscopy.
- What could go wrong
- This is a small, early-stage diagnostic comparison study. 3D ultrasound may not be accurate enough to replace hysteroscopy, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 106 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Any pattern of abnormal uterine bleeding as menorrhagia or metrorrhagia for more than 3 months at age between 40 and 55 years , and no ovarian lesion or local cause of bleeding as vaginal or cervical ulcer Exclusion Criteria: * • Women with postmenopausal bleeding. * Systemic causes of perimenopausal bleeding DM Hypertension or chronic liver disease. * Women on hormonal therapy or using any contraception as IUD. * Women have contraindication for hysteroscopy as cervical stenosis or pregnancy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Perimenopausal bleeding are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sohag University
RECRUITINGSohag, Egypt